prazosin hydrochloride

Generic: prazosin hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prazosin hydrochloride
Generic Name prazosin hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

prazosin hydrochloride 5 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-814
Product ID 71610-814_1547c4d1-e65a-275c-e063-6294a90a8329
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA072575
Listing Expiration 2026-12-31
Marketing Start 1989-05-16

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610814
Hyphenated Format 71610-814

Supplemental Identifiers

RxCUI
198141
UNII
X0Z7454B90

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prazosin hydrochloride (source: ndc)
Generic Name prazosin hydrochloride (source: ndc)
Application Number ANDA072575 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 1250 CAPSULE in 1 BOTTLE (71610-814-27)
source: ndc

Packages (1)

Ingredients (1)

prazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1547c4d1-e65a-275c-e063-6294a90a8329", "openfda": {"unii": ["X0Z7454B90"], "rxcui": ["198141"], "spl_set_id": ["15479b91-add3-e5dd-e063-6294a90ac15a"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1250 CAPSULE in 1 BOTTLE (71610-814-27)", "package_ndc": "71610-814-27", "marketing_start_date": "20240403"}], "brand_name": "Prazosin Hydrochloride", "product_id": "71610-814_1547c4d1-e65a-275c-e063-6294a90a8329", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-814", "generic_name": "prazosin hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prazosin Hydrochloride", "active_ingredients": [{"name": "PRAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA072575", "marketing_category": "ANDA", "marketing_start_date": "19890516", "listing_expiration_date": "20261231"}